he emergence of acquired carbapenemases is currently one of the most serious public health threats worldwide. These enzymes confer resistance to almost all ␤-lactams, including carbapenems leading to very few therapeutic options for treating patients infected by multidrug-resistant bacteria.
Conjugation assays were performed in liquid medium using the azide-resistant E. coli J53 as the recipient strain. Transconjugants were selected onto Luria-Bertani agar plates supplemented with ertapenem (2 mg/liter) and azide (100 mg/liter) to detect the transfer of the carbapenemase genes. Transconjugants were obtained for three out of the four isolates, but not for strain E202 despite repeated attempts. Plasmid extractions were performed using the Kieser extraction method (6) using the environmental strains and transconjugants. Further analysis showed that the bla VIM-1 and bla IMP-8 genes were carried on a ca. 150-kb plasmid. Molecular typing of plasmids was performed using the PCR-based replicon typing (Diatheva, Fano, Italy) (7), revealing that all plasmids bearing the carbapenemase genes belonged to the IncFIB group.
The failure to obtain a transconjugant or transformant from strain E202 suggests a possible chromosomal location of the bla VIM-34 gene. It is noteworthy that the bla VIM-34 gene was previously identified from Klebsiella pneumoniae in Portugal in 2013 and was found to be located on the chromosome (8). PCR mapping followed by sequencing revealed that the bla VIM-34 gene was embedded in class 1 integron In817 in strain E202, the exact same structure as identified in the K. pneumoniae isolate from Portugal (8) .
The occurrence of carbapenemase-producing E. coli strains in the aquatic environment remains worrying. Interestingly, we first identified a KPC-producing E. coli in Portugal from the same 
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river, as early as 2010 (9) . This river may be a source of carbapenemase-producing E. coli or, conversely, humans might be the source of this environmental contamination. Note that IMP-8 producers have been reported in Portugal (10) in K. pneumoniae and Pseudomonas aeruginosa clinical isolates (11) , suggesting a wide spread of this carbapenemase, which is not commonly identified in other European countries. Finally, monitoring the occurrence of carbapenemase-producing members of the family Enterobacteriaceae in the environment can be of interest, since it may contribute to better control of the occurrence and spread of these bacteria. It is therefore mandatory to screen for carbapenemase producers not only among the hospitalized populations but also among healthy people and potential environmental cradles in order to identify possible hidden reservoirs.
